Hi CMAG members,
The Allergies/Hypersensitivity and Intolerance Clinical Reference Group is seeking information on which countries are using the allergy to substance concepts e.g. 417532002 |Allergy to fish (finding)| rather than just documenting allergies using substance and product concepts. Would you please advise the approach in your country here: Concepts used for documenting allergies Due date has been made 24 December. if further time is required please email me.
Please be advised the work item X finding not seen - content planned for inactivation has been closed. We will not be proceeding with inactivation of this content at this point.
We are seeking input from members on how navigational concepts are being used in your country. Please provide your response here Use of navigational concepts by Monday 6th January 2020.
Attached please find the first two of a series of briefing notes that were sent to the Member Forum to update them on the content improvements in the Substance and Product hierarchies. For further reference, this project group’s Confluence space is located at: Drugs Project Please contact firstname.lastname@example.org with any inquiries.
Hi all CMAG members,
Please be advised that the review period for the following items has now past and the action items have been closed. Thank you to those who provided input.
- 2020 CMAG workplan
- CMAG Terms of Reference
- Laboratory findings values
As advised at the October meeting, the Declarations of Interest page need to be updated by group members. If you have not yet updated your DOI please do so by Wednesday 4th December.
And finally a reminder that the due date for feedback on X finding not seen - content planned for inactivation is
Please be advised that there is a Community of Practice consultation for Concrete Domains . Please see Concrete Domains - Community of Practice Consultation for details.
Hi all CMAG members,
After completion of the consultation period for discussion about: National content identified by a second country as useful a draft document (link below) has been developed and is now out for review.
Please provide any feedback on the draft guidelines by Monday 7th October.
Attached please find a briefing note that was sent to the Member Forum to update them on the establishment and activities of the Devices Working Group. For further reference, this project group's Confluence space is located at: https://confluence.ihtsdotools.org/display/IAP/Devices+Project
Please contact email@example.com with any inquiries.
The Drug Concept Model - Editorial Guidelines for Modeling and Terming v1.0.pdf document has been updated on the project group site.
Dear CMAG members,
Please note that today is the deadline for submission of responses regarding the first stage of the Administrative concept review. Here are the instructions provided earlier:
Deadline - January 31st, 2019
3 areas have been prioritised for review:
- Tab: Administrative status - 309012006 |Referral statuses (finding)| and subtypes
- Tab: Administrative status - 307827002 |Registration status (finding)| and subtypes
- Tab: Administrative procedures - 3457005 |Patient referral (procedure)| and subtypes
In the spreadsheet, please answer these questions for each:
- Do you have a use case?
- Can you provide a definition?
- Which is correct grammatical format/tense e.g. "referred to" or "referral to" - establish most appropriate and internationally applicable.
- Provide any other information which may be of use. "
Best wishes, Monica
On-going status of the project can be tracked using following links in the correct sequence as advised below. The first link will show you the JIRA tickets, which are either completed or in progress. Each ticket documents progress of a a sub-hierarchy or part of it, by using the second link you can track the Clinical findings, the JIRA tickets refer to. For example QI-20 about 125666000 |Burn| is completed, by searching for "125666000" in the daily build on the second link, you will find what had been done to "Burn"
- Quality Initiative - Clinical Findings QI Scope, Process and Risk#ClinicalFindingsQIScope,ProcessandRisk-5.Progress
SNOMED Content team
Please be advised Monica and I are cancelling the January 2019 CMAG meeting given the size of the current agenda. We will next meet on Tuesday 12th February at 2000UTC.
Further to the discussion at the December CMAG meeting, a subset of Administrative content has been selected for first stage review. Information on the subset and the review is located: 2019 Administrative Content work. An action item has been set up for each group member.
Please be advised of this change, you can find the detail in the following link.
A confluence page has been set up to provide information on the scope, processes, risks and weekly status of the current QI work: Quality Initiative - Clinical Findings QI Scope, Process and Risk - Under Construction.